Course Provider
Learning Objectives
Recall the prevalence, transmission risks, screening recommendations and pathophysiology of chronic hepatitis C (HCV).
Recognize the natural disease course and complications.
Recall the characteristics of traditional chronic HCV therapy including contraindications and common adverse effects.
Recall the complexities unique to each of the newer classes of HCV therapy (i.e. protease inhibitors and polymerase inhibitors).
Recall current evidence based recommendations of national practice standards (e.g. American Association for the Study of Liver Disease and the Infectious Disease Society of America).
Gain an appreciation for investigational therapies on the horizon and their potential impact on current treatment paradigms.